These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18680516)

  • 1. No association of the CD45 77C>G transversion with inflammatory bowel disease in German patients.
    Thude H; Rebstock K; Blume J; Lutz B; Barz D
    Int J Immunogenet; 2008 Aug; 35(4-5):335-7. PubMed ID: 18680516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between transmembrane protein-tyrosine-phosphatase receptor type C (CD45) exon A 77C>G transversion and Hashimoto's thyroiditis in a German population.
    Thude H; Weissenborn S; Vilser C; Müller UA; Kloos C; Wolf G; Beck J; Barz D
    Hum Immunol; 2010 Feb; 71(2):220-3. PubMed ID: 19879912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77C>G) and idiopathic dilated cardiomyopathy.
    Thude H; Gerlach K; Richartz B; Krack A; Brenke B; Pethig K; Figulla HR; Barz D
    Hum Immunol; 2005 Sep; 66(9):1008-12. PubMed ID: 16360841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77 C to G) is not associated with the development of type 1 diabetes mellitus in a German population.
    Thude H; Rosenhahn S; Hunger-Dathe W; Müller UA; Barz D
    Eur J Immunogenet; 2004 Dec; 31(6):245-7. PubMed ID: 15548260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.
    Schwinzer R; Witte T; Hundrieser J; Ehlers S; Momot T; Hunzelmann N; Krieg T; Schmidt RE; Wonigeit K
    Genes Immun; 2003 Mar; 4(2):168-9. PubMed ID: 12618866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does 77C-->G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus?
    Vorechovsky I; Kralovicova J; Tchilian E; Masterman T; Zhang Z; Ferry B; Misbah S; Chapel H; Webster D; Hellgren D; Anvret M; Hillert J; Hammarstrom L; Beverley PC
    Nat Genet; 2001 Sep; 29(1):22-3. PubMed ID: 11548742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q; Zhu Q; Shang Y; Gao M; Si J
    Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between expression of inhibitory killer cell immunoglobulin-like receptor HLA-Cw ligand and susceptibility to inflammatory bowel disease].
    Zhang HX; Li JC; Liu ZJ
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3108-11. PubMed ID: 19159590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
    Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
    Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population.
    Marrakchi R; Moussa A; Ouerhani S; Bougatef K; Bouhaha R; Messai Y; Rouissi K; Khadimallah I; Khodjet-el-Khil H; Najar T; Benammar-Elgaaeid A
    Inflamm Res; 2009 Mar; 58(3):155-60. PubMed ID: 19184348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear pregnane X receptor single nucleotide polymorphism (-25385C/T) is not associated with inflammatory bowel disease in pediatric patients.
    Lacher M; Kappler R; Schroepf S; Berkholz S; Ballauff A; Bufler P; Baurecht H; von Schweinitz D; Koletzko S
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):147-50. PubMed ID: 19516190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population.
    Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P
    Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C; Magowan S; Accortt NA; Chen J; Stone CD
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of alpha- and beta-defensins in plasma of patients with inflammatory bowel disease.
    Yamaguchi N; Isomoto H; Mukae H; Ishimoto H; Ohnita K; Shikuwa S; Mizuta Y; Nakazato M; Kohno S
    Inflamm Res; 2009 Apr; 58(4):192-7. PubMed ID: 19184352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
    Glas J; Seiderer J; Pasciuto G; Tillack C; Diegelmann J; Pfennig S; Konrad A; Schmechel S; Wetzke M; Török HP; Stallhofer J; Jürgens M; Griga T; Klein W; Epplen JT; Schiemann U; Mussack T; Lohse P; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Mar; 104(3):665-72. PubMed ID: 19262523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between transmembrane protein-tyrosine phosphatase receptor type C (PTPRC) exon A 77C>G transversion and liver transplant rejection.
    Thude H; Schipler AD; Treszl A; Sterneck M; Nashan B
    Int J Immunogenet; 2012 Oct; 39(5):437-41. PubMed ID: 22524693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the epidemiology of inflammatory bowel disease in Asia.
    Thia KT; Loftus EV; Sandborn WJ; Yang SK
    Am J Gastroenterol; 2008 Dec; 103(12):3167-82. PubMed ID: 19086963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
    Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP
    Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.